RPID · Rapid Micro Biosystems Inc
United States · RS rating 5 · As of 2026-11-03
| Price | 0.69 USD |
|---|---|
| 1-day change | -1.6% |
| RS rating (overall / 1M / 3M / 12M) | 5 / 13 / 4 / 10 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 20 / 5 / 22 |
| Industry group (rank) | Medical-Research Eqp/Svc (46) |
| EPS growth Q/Q | +3.7% |
| Sales growth Q/Q | +7.9% |
| Distance from 52-week high | +85.2% |
| Market cap (USD) | $103.0M |